Correction of a release from 08.07.2015, 10:33 CET - STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Correction of the release from 8 July 2015
Ameriprise International Holdings GmbH, Zug, Switzerland, has notified us
on 3 July 2015 pursuant to § 21 sec. 1 WpHG that on 29 June 2015 the share
of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001, exceeded the threshold of 3% and amounted on that day to
4.87% (575,168 voting rights). The voting rights are attributable pusuant
to § 22 para. 1 sent. 1 No. 6 in connection with sent. 2 WpHG. Shareholder,
which voting rights are attributed and equal or exceed 3%: Threadneedle
Investment Funds ICVC.
08.07.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Company: STRATEC Biomedical AG
End of Announcement DGAP News-Service